These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21722820)

  • 1. Association between CTLA-4 exon-1 +49A>G polymorphism and primary biliary cirrhosis risk: a meta-analysis.
    Huang Q; Shao F; Wang C; Qiu LJ; Hu YG; Yu JH
    Arch Med Res; 2011 Apr; 42(3):235-8. PubMed ID: 21722820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis.
    Zhang Y; Zhang J; Deng Y; Tian C; Li X; Huang J; Fan H
    Cancer; 2011 Sep; 117(18):4312-24. PubMed ID: 21387262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of cytotoxic T lymphocyte antigen-4 +49A/G polymorphism and cancer risk: An updated meta-analysis.
    Gao X; Zhang S; Qiao X; Yao Y; Wang L; Dong D; Ma X; Wang T
    Cancer Biomark; 2014; 14(4):287-94. PubMed ID: 24934372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis: the relationship between CTLA-4 +49 A/G polymorphism and primary biliary cirrhosis and type I autoimmune hepatitis.
    Eskandari-Nasab E; Tahmasebi A; Hashemi M
    Immunol Invest; 2015; 44(4):331-48. PubMed ID: 25942345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
    Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
    Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer: a meta-analysis.
    Li D; Liu H; Yan L; Tang Y; Ren J; Xu Z
    Urol Int; 2012; 88(1):88-94. PubMed ID: 22156293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects.
    Yu KD; Di GH; Fan L; Chen AX; Yang C; Shao ZM
    Breast Cancer Res Treat; 2010 Jul; 122(2):483-8. PubMed ID: 20043205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients.
    Zhu CL; Huang Q; Liu CH; Xie F
    Mol Biol Rep; 2012 Sep; 39(9):8701-8. PubMed ID: 22711308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
    Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
    Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between IGF1 CA repeat polymorphisms and breast cancer risk: a meta-analysis.
    Huang Q; Wang C; Qiu LJ; Shao F; Yu JH
    Breast Cancer Res Treat; 2011 Aug; 129(1):191-4. PubMed ID: 21390492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis.
    Yu KD; Chen AX; Shao ZM
    Breast Cancer Res Treat; 2010 Aug; 122(3):853-8. PubMed ID: 20076999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
    Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
    Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls.
    Qiu LX; Yao L; Yuan H; Mao C; Chen B; Zhan P; Xue K; Zhang J; Hu XC
    Breast Cancer Res Treat; 2010 Aug; 122(3):867-71. PubMed ID: 20084546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case-control studies.
    Liang J; Zhang S; Luo Q; Li W; Tian X; Zhang F; Zhao T; Chen X; Zhang X
    Gene; 2015 Sep; 568(2):196-202. PubMed ID: 26013045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T-lymphocyte associated antigen-4 gene polymorphisms and primary biliary cirrhosis: a systematic review.
    Li M; Zheng H; Li T; Gao P; Zhang XL; Liu DW
    J Gastroenterol Hepatol; 2012 Jul; 27(7):1159-66. PubMed ID: 22414241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA-4 +49A/G and CT60 gene polymorphisms in primary Sjögren syndrome.
    Gottenberg JE; Loiseau P; Azarian M; Chen C; Cagnard N; Hachulla E; Puechal X; Sibilia J; Charron D; Mariette X; Miceli-Richard C
    Arthritis Res Ther; 2007; 9(2):R24. PubMed ID: 17341301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the polymorphisms of tumor necrosis factor-α gene on the susceptibility to primary biliary cirrhosis: a meta-analysis.
    Qin B; Liang Y; Yang Z; Zhong R
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1386-92. PubMed ID: 23011034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis.
    Qiu LX; Mao C; Yao L; Yu KD; Zhan P; Chen B; Liu HG; Yuan H; Zhang J; Xue K; Hu XC
    Breast Cancer Res Treat; 2010 Jul; 122(2):489-93. PubMed ID: 20049524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour necrosis factor alpha -308G/A polymorphism and risk of the four most frequent cancers: a meta-analysis.
    Wang J; Cao C; Luo H; Xiong S; Xu Y; Xiong W
    Int J Immunogenet; 2011 Aug; 38(4):311-20. PubMed ID: 21624061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis.
    Yu KD; Chen AX; Yang C; Qiu LX; Fan L; Xu WH; Shao ZM
    Breast Cancer Res Treat; 2010 Jul; 122(1):251-7. PubMed ID: 20033767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.